Kyowa Kirin wins European Crysvita approval for infants from one month of age
Crysvita wins European Union approval for infants from one month, widening early XLH treatment and strengthening Kyowa Kirin’s rare disease franchise.
Pharma & Biotech
Medical Devices & Diagnostics
Why is AdaptHealth selling a $592m diabetes business while Cardinal Health doubles down?
AdaptHealth will sell its Diabetes Health business to Cardinal Health for $235 million, shifting 225,000 patients into a larger home-care platform.
Pharma & Biotech
Aptar Beauty’s Dermalogica debut puts its automatic skincare dropper to the real market test
Aptar Beauty’s NeoDropper Autoload debuts with Dermalogica, testing precision dosing, formula protection and premium skincare adoption.
Pharma & Biotech
Could Ebglyss challenge Dupixent in younger children? Almirall clears a crucial EMA filing hurdle
Almirall’s Ebglyss paediatric filing enters EMA review, opening a potential path into Europe’s childhood atopic dermatitis market.
Pharma & Biotech
Why Innate Pharma’s 76-patient IPH4502 milestone is only half the Nectin-4 story
Innate Pharma completed IPH4502 dose-escalation enrollment, putting safety, response durability and dose selection at the center of a year-end readout.
Pharma & Biotech
Why Incyte’s ESMO 2026 oncology readouts matter for its expanding Phase 3 pipeline
Incyte’s ESMO 2026 programme puts three investigational cancer assets under scrutiny across pancreatic, colorectal and ovarian tumours.
Pharma & Biotech
Bristol Myers Squibb is building a vast NVIDIA AI factory, but can it improve drug discovery odds?
Bristol Myers Squibb is scaling NVIDIA-powered drug discovery. Can more computing power deliver faster, higher-confidence pipeline decisions?
Pharma & Biotech
Galderma is taking Alastin deeper into Asia, but this launch is about more than skincare
Galderma expands Alastin across Japan and Asia Pacific, linking premium skincare with rising demand for aesthetic procedures.
Pharma & Biotech
Why this Dana-Farber collaboration is looking beyond survival in metastatic inflammatory breast cancer
Dana-Farber and Ohio State unite to study how local treatment affects quality of life in metastatic inflammatory breast cancer.
Medical Devices & Diagnostics
Poriferous patented a cranial implant designed to grow in on one side and let go on the other
Poriferous has patented DuraBloc, a dual-surface cranial implant designed to support tissue ingrowth while easing potential revision surgery.